BCAX BICARA THERAPEUTICS INC
Health Care · Russell 2000
Next earnings: Mon 9 Nov 2026 · before market open
What 21 analyst firms say about BICARA THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
20 rated views · 21 analyst/firm records · 21 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8069
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8041
Recent analyst activity · last 90 days
Our tracked history has 19 reports on BCAX from 13 analyst firms in the last 90 days (21 firms in the past year).
Comparing each firm's latest target with its previous one: 4 raised their price target, 1 lowered it, 2 left it unchanged and 1 has its first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: Wedbush lowered its target from $33.00 (set 12 Aug 2026) to $24.00 on 29 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Tazeen Ahmad | Buy | 25 Mar 2026 | 35.00 USD |
| Benchmark | Unnamed analyst | Buy | 29 Oct 2026 | — |
| BMO Capital Markets | David Lebowitz | Buy | 18 Aug 2026 | 35.00 USD |
| BTIG | Jeet Mukherjee | Buy | 19 Oct 2026 | 39.00 USD |
| Cantor Fitzgerald | Eric Schmidt | Buy | 10 Sep 2026 | — |
| Citigroup | Unnamed analyst | Buy | 21 Aug 2026 | — |
| Citizens JMP | Reni Benjamin | Buy | 31 Mar 2026 | 31.00 USD |
| Goldman Sachs | Richard Law | Sell | 30 Oct 2026 | Conflicting reports · excluded |
| Guggenheim | Brad Canino | Buy | 11 May 2026 | 42.00 USD |
| H.C. Wainwright | Robert Burns | Buy | 1 Jun 2026 | 42.00 USD |
| HSBC | Unnamed analyst | Hold | 22 Sep 2026 | — |
| Jonestrading | Soumit Roy | Buy | 1 Jul 2026 | 30.00 USD |
| Mizuho | Joseph Catanzaro | Hold | 12 Aug 2026 | 20.00 USD |
| Morgan Stanley | Sean Laaman | Buy | 20 Oct 2026 | — |
| Piper Sandler | Kelsey Goodwin | Buy | 11 Aug 2026 | 36.00 USD |
| TD Cowen | Tyler Van Buren | Buy | 15 Jun 2026 | — |
| UBS | Unnamed analyst | Buy | 14 Jan 2026 | — |
| Wedbush | David Nierengarten | Buy | 29 Oct 2026 | 24.00 USD |
| Weiss Ratings | Unnamed analyst | — | 2 Oct 2026 | — |
| Wells Fargo | Eva Fortea-Verdejo | Hold | 12 Aug 2026 | 23.00 USD |
| Data feed RESEARCH | Research Team | Hold | 14 Apr 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:10 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.